Janux Therapeutics
JANX
JANX
189 hedge funds and large institutions have $828M invested in Janux Therapeutics in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 66 increasing their positions, 53 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
4% less capital invested
Capital invested by funds: $860M → $828M (-$32.1M)
5.47% less ownership
Funds ownership: 103.42% → 97.95% (-5.5%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
189
Holding in Top 10
1
Calls
$7.2M
Puts
$6.69M
Top Buyers
| 1 | +$18.6M | |
| 2 | +$15.9M | |
| 3 | +$15.1M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$11.1M |
| 5 |
ICM
Irenic Capital Management
New York
|
+$10.5M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$15.8M | |
| 3 | -$13.4M | |
| 4 |
O
OrbiMed
New York
|
-$13.3M |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
-$10.6M |
